1
Abacavir Sulphate 300 mg
HIV, Pharmaceutical Products
Abacavir Sulphate 300 mg
Abamune 300 mg Tablet contains Abacavir Sulphate 300 mg, an NRTI used in combination therapy for HIV-1 infection.
Form: Film-coated tablet
Manufacturer: Cipla Ltd.
Country of Origin: India
| Composition | Abacavir Sulphate 300 mg |
|---|---|
| Pack Size | Strip of 30 tablets |
| Form | Film-coated tablet |
| Manufacturer | Cipla Ltd. |
| Country of Origin | India |
| Dosage Regimen | One tablet once or twice daily (as prescribed) |
| Usage Category | Antiretroviral Therapy (HIV-1) |
| Usage Indications | HIV-1 infection (as part of combination ART) |
| Administration Route | Oral – swallow with water |
| Prescription Status | Rx required |
| Storage Conditions | protect from moisture, Store below 30 °C |
| Shelf Life | 24 months (typical) |
| Side Effects | diarrhoea; rare hypersensitivity reactions, fatigue, headache, Nausea, rash |






Reviews
There are no reviews yet.